[Federal Register Volume 64, Number 62 (Thursday, April 1, 1999)]
[Notices]
[Page 15807]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-7937]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances, Notice of Registration

    By Notice dated December 10, 1998, and published in the Federal 
Register on December 23, 1998 (63 FR 71156), Irix Pharmaceuticals, 
Inc., 101 Technology Place, Forence, South Carolina 29501, made 
application to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of methylphenidate (1724), a basic 
class of controlled substance listed in Schedule II.
    The firm plans to manufacture methylphenidate for demonstration 
purposes and for dosage form development and stability studies.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Irix 
Pharmaceuticals, Inc. to manufacture the listed controlled substance is 
consistent with the public interest at this time. DEA has investigated 
Irix Pharmaceuticals, Inc. to ensure that the company's registration is 
consistent with the public interest. Therefore, pursuant to 21 U.S.C. 
823 and 28 CFR. 0.100 and 0.104, the Deputy Assistant Administrator, 
Office of Diversion Control, hereby orders that the application 
submitted by the above firm for registration as a bulk manufacturer of 
the basic class of controlled substance listed above is granted.

    Dated: March 17, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-7937 Filed 3-31-99; 8:45 am]
BILLING CODE 4410-09-M